- Oragenics (NYSE:OGEN) said on Monday it was proposing to offer and sell shares of its common stock (or pre-funded warrants) in a public offering.
- Shares of OGEN fell 6.02% in extended trading.
- The company said that all the securities to be sold in the offering are to be offered by Oragenics.
- OGEN plans to use the offering to fund the continued development of its ONP-002 product candidate and for general corporate purposes and working capital.
